• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.美国骨科学会作者反思：避免腋窝淋巴结清扫术：新辅助化疗对隐匿性原发性乳腺癌的益处。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):865-866. doi: 10.1245/s10434-020-08939-z. Epub 2020 Jul 28.
2
ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.ASO作者反思：新辅助化疗病理反应后仅接受前哨淋巴结活检的临床淋巴结阳性乳腺癌患者腋窝复发率低
Ann Surg Oncol. 2021 May;28(5):2630-2631. doi: 10.1245/s10434-020-09259-y. Epub 2020 Oct 29.
3
ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?ASO作者反思：新辅助化疗后对淋巴结阳性乳腺癌进行前哨淋巴结手术：从肿瘤学角度看是否安全？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.
4
ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.ASO作者反思：临床淋巴结阴性患者新辅助化疗后前哨淋巴结切除在切除三个淋巴结后可停止。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):848-849. doi: 10.1245/s10434-020-08874-z. Epub 2020 Jul 21.
5
ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?ASO作者反思：新辅助化疗后仍有N1淋巴结残留疾病的乳腺癌患者省略腋窝淋巴结清扫术：时机尚不成熟？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):869-870. doi: 10.1245/s10434-020-08966-w. Epub 2020 Jul 31.
6
Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.乳腺癌中经术前活检阳性腋窝淋巴结穿刺定位标记的靶向腋窝淋巴结清扫术。
Neoplasma. 2020 Nov;67(6):1329-1334. doi: 10.4149/neo_2020_191228N1344. Epub 2020 Aug 4.
7
Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.新辅助化疗后乳腺癌患者的靶向腋窝清扫和前哨淋巴结活检——一项回顾性研究
Rozhl Chir. 2018 Winter;97(12):551-557.
8
Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?新辅助化疗后对临床淋巴结阳性乳腺癌患者省略腋窝淋巴结清扫术：我们如何选择患者？
Breast J. 2020 Sep;26(9):1869-1870. doi: 10.1111/tbj.13930. Epub 2020 Jun 10.
9
[Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].[新辅助化疗后乳腺癌前哨淋巴结活检]
Magy Onkol. 2011 Jun;55(2):73-84. Epub 2011 Feb 2.
10
Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.一步法核酸扩增（OSNA）术中前哨淋巴结活检可避免新辅助化疗治疗乳腺癌女性行腋窝淋巴结清扫术。
Eur J Surg Oncol. 2013 Aug;39(8):873-9. doi: 10.1016/j.ejso.2013.05.002. Epub 2013 May 25.

引用本文的文献

1
Best treatment options for occult breast cancer: A meta-analysis.隐匿性乳腺癌的最佳治疗方案：一项荟萃分析。
Front Oncol. 2023 May 12;13:1051232. doi: 10.3389/fonc.2023.1051232. eCollection 2023.

本文引用的文献

1
Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.新辅助化疗后隐匿性原发性乳腺癌腋窝降期。
Ann Surg Oncol. 2021 Feb;28(2):968-974. doi: 10.1245/s10434-020-08863-2. Epub 2020 Aug 19.
2
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.对于经组织学证实有淋巴结转移的患者，新辅助化疗能使腋窝淋巴结清扫术避免实施的频率如何？一项前瞻性研究的结果
Ann Surg Oncol. 2016 Oct;23(11):3467-3474. doi: 10.1245/s10434-016-5246-8. Epub 2016 May 9.
3
The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis.新辅助全身治疗后病理确诊淋巴结阳性乳腺癌患者前哨淋巴结活检的诊断性能：一项系统评价和荟萃分析。
Eur J Surg Oncol. 2015 Oct;41(10):1278-87. doi: 10.1016/j.ejso.2015.07.020. Epub 2015 Aug 22.
4
Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.肿瘤生物学与乳腺癌新辅助化疗后保乳手术和病理完全缓解率相关：来自 ACOSOG Z1071（Alliance）前瞻性多中心临床试验的结果。
Ann Surg. 2014 Oct;260(4):608-14; discussion 614-6. doi: 10.1097/SLA.0000000000000924.

ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.

作者信息

Botty van den Bruele Astrid, Plitas George, Pilewskie Melissa

机构信息

Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Ann Surg Oncol. 2020 Dec;27(Suppl 3):865-866. doi: 10.1245/s10434-020-08939-z. Epub 2020 Jul 28.

DOI:10.1245/s10434-020-08939-z
PMID:32725524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7680299/
Abstract
摘要